Stockreport

NephroGenex, Inc. Prices $7,500,000 Public Offering

NEPHROGENEX  (NRX) 
PDF RALEIGH, N.C.--(BUSINESS WIRE)-- NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney diseas [Read more]